Valuence Merger Corp. I (VMCA) versus The Competition Critical Analysis

Volatility & Risk

Valuence Merger Corp. I has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Valuence Merger Corp. I’s peers have a beta of 0.02, suggesting that their average share price is 98% less volatile than the S&P 500.

Profitability

This table compares Valuence Merger Corp. I and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Valuence Merger Corp. I	N/A	-12.48%	2.90%
Valuence Merger Corp. I Competitors	14.76%	-42.62%	2.05%

Earnings and Valuation

This table compares Valuence Merger Corp. I and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Valuence Merger Corp. I	N/A	$4.77 million	71.88
Valuence Merger Corp. I Competitors	$1.06 billion	$87.25 million	66.06

Valuence Merger Corp. I’s peers have higher revenue and earnings than Valuence Merger Corp. I. Valuence Merger Corp. I is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

52.2% of Valuence Merger Corp. I shares are held by institutional investors. Comparatively, 54.4% of shares of all “Holding & other investment offices” companies are held by institutional investors. 47.0% of Valuence Merger Corp. I shares are held by company insiders. Comparatively, 26.9% of shares of all “Holding & other investment offices” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Valuence Merger Corp. I peers beat Valuence Merger Corp. I on 5 of the 9 factors compared.

Valuence Merger Corp. I Company Profile

Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia. The company was incorporated in 2021 and is based in Orinda, California.